CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1/2-dependent S100A4-upregulated pathway.
Chen PS, Wang MY, Wu SN, Su JL, Hong CC, Chuang SE, Chen MW, Hua KT, Wu YL, Cha ST, Babu MS, Chen CN, Lee PH, Chang KJ, Kuo ML.
J Cell Sci. 2007 Jun 15;120(Pt 12):2053-65.PMID: 17550972 [PubMed - indexed for MEDLINE]Related articlesFree article